Literature DB >> 3548731

Mast cell numbers in rheumatoid synovial tissues. Correlations with quantitative measures of lymphocytic infiltration and modulation by antiinflammatory therapy.

D G Malone, R L Wilder, A M Saavedra-Delgado, D D Metcalfe.   

Abstract

Synovial biopsy specimens from 20 patients with rheumatoid arthritis were subjected to quantitative analysis for several parameters of inflammation and for enumeration of synovial tissue mast cells. Strong positive correlations were found between numbers of mast cells per cubic millimeter of synovial tissue and the following synovial tissue parameters: inflammatory index (a quantification of lymphocytic infiltration), Leu-3a grade (T helper/inducer lymphocytes), Leu-1 grade (T lymphocyte), and plasma cell grade. A strong negative correlation was found between the synovial mast cell count and the extent of sublining layer fibrin deposition. Correlations between synovial mast cell count and Leu-2a grade, ratio of Leu-3a grade:Leu-2a grade, OKM1 grade, HLA-DR grade, and lining layer thickness grade did not reach statistical significance. In addition, we obtained synovial specimens from 6 of the patients both before and after long-term therapy with oral methotrexate and from 3 of the patients before, and 1 week after, an intraarticular injection of steroid. The 3 patients who had an intraarticular steroid injection showed a 67-96% decrease in the number of synovial tissue mast cells; there was no significant change in the number of synovial mast cells in the tissues of the 6 patients who received oral methotrexate. These observations are the first documentation of a quantitative relationship between the number of mast cells and the number and phenotypic profile of infiltrating lymphocytes in an inflamed tissue, which in this case, is human synovium. Our findings suggest that mast cells are involved in the pathologic interactions in rheumatoid arthritis and might play a role in the early phases of exacerbations of disease activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3548731     DOI: 10.1002/art.1780300202

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  26 in total

Review 1.  Tryptase and chymase, markers of distinct types of human mast cells.

Authors:  S S Craig; L B Schwartz
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

2.  The neo-synovial membrane of patients with active rheumatoid arthritis at resynovectomy. Histomorphological and immunohistological evaluations.

Authors:  J G Saal; P Fritz; B J Maschek; A Mischlinski; W Laschner
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

3.  Food intolerance in rheumatoid arthritis. II. Clinical and histological aspects.

Authors:  M A van de Laar; M Aalbers; F G Bruins; A C van Dinther-Janssen; J K van der Korst; C J Meijer
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

4.  Hyperplastic synoviocytes from rats with streptococcal cell wall-induced arthritis exhibit a transformed phenotype that is thymic-dependent and retinoid inhibitable.

Authors:  D E Yocum; R Lafyatis; E F Remmers; H R Schumacher; R L Wilder
Journal:  Am J Pathol       Date:  1988-07       Impact factor: 4.307

5.  Optical imaging of experimental arthritis using allogeneic leukocytes labeled with a near-infrared fluorescent probe.

Authors:  Gerhard H Simon; Heike E Daldrup-Link; Juli Kau; Stephan Metz; Juergen Schlegel; Guido Piontek; Olaf Saborowski; Stavros Demos; Justus Duyster; Bernd J Pichler
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-06-13       Impact factor: 9.236

6.  Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation.

Authors:  B L Gruber; M J Marchese; K Suzuki; L B Schwartz; Y Okada; H Nagase; N S Ramamurthy
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

7.  Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma.

Authors:  Z Qu; J M Liebler; M R Powers; T Galey; P Ahmadi; X N Huang; J C Ansel; J H Butterfield; S R Planck; J T Rosenbaum
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

8.  Effect of NGF antibodies on mast cell distribution, histamine and substance P levels in the knee joint of TNF-arthritic transgenic mice.

Authors:  L Aloe; L Probert; G Kollias; A Micera; P Tirassa
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

9.  Mast cell activation in human synovium explants by calcium ionophore A23187, compound 48/80, and rabbit IgG anti-human IgE, but not morphine sulfate.

Authors:  J W Verbsky; P K McAllister; D G Malone
Journal:  Inflamm Res       Date:  1996-01       Impact factor: 4.575

Review 10.  Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders.

Authors:  B M Jensen; C Akin; A M Gilfillan
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.